Phase 1 Study of AWT020 in Advanced Cancer

Summary

The aims of this clinical trial are (1) to assess the safety of AWT020 at different dose levels; (2) to determine the pharmacokinetics and pharmacodynamics of AWT020 in subjects with locally advanced or metastatic cancer who have failed standard therapy.

Timeline

Start

2023-09-15

Primary completion

2026-06-30

Completion

2026-09-30

Drugs

Indications